N4 Pharma's latest press release regarding Nuvec®, an engineered silica nanoparticle, which has been designed for the intracellular delivery of large nucleic acids such as pDNA and mRNA and is in the advanced research phase.
N4 Pharma Plc (AIM: N4P), a specialist pharmaceutical company, is developing Nuvec® – a unique non-viral adjuvant delivery system for vaccines and can ...
Satisfied Users & 
Approved Press Releases
